The Joint Committee on Ways and Means of the Oregon Legislature convened on May 2, 2025, to discuss various topics, with a significant focus on cannabis regulation and testing standards.

During the meeting, a senator raised concerns about the rising THC levels in cannabis products over recent decades. The senator questioned whether laboratories set THC levels to minimize addiction rates or to maximize sales. This inquiry prompted a response from Michelle Dicer of the Legislative Fiscal Office, who clarified that it is the producers of marijuana who determine the potency of their strains. The reference laboratories primarily confirm the accuracy of the potency reported on product labels, rather than setting the levels themselves.

The discussion highlighted the complexities of cannabis regulation and the role of laboratories in ensuring product safety and transparency. The committee's exploration of these issues reflects ongoing efforts to address public health concerns related to cannabis consumption.

As the meeting progressed, further discussions were anticipated, indicating that the committee is actively engaging with the implications of cannabis testing and regulation in Oregon. The outcomes of these discussions may influence future legislative actions regarding cannabis policy in the state.